Review decision: November 2015
We checked this guideline and decided that it should be updated at this time. For details, see the update decision, decision matrix and the process for deciding if an update is needed. Details of the update will be available on the guidelines in development webpage in due course. This guideline will be checked again for update at its scheduled time point according to the methods described here.
Next review date: 2017
The advice in the NICE guideline describes the tests, treatment, care and support that patients with advanced breast cancer should be offered.
It does not specifically describe the care of patients with early breast cancer or those with rare or non-cancerous tumours of the breast.
This guideline was previously called advanced breast cancer (update): diagnosis and treatment.
The addendum to NICE clinical guideline 81 has added recommendations on exercise in people with or at risk of breast-cancer-related lymphoedema to section 1.5 of the NICE guideline. The addendum also contains details of the methods and evidence used to update these recommendations. The recommendations in exercise in lymphoedema are also relevant for people with early or locally advanced breast cancer.
The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The application of the recommendations in this guideline is not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.
Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.